Stephens & Co. Reiterates Overweight on Avid Bioservices, Maintains $24 Price Target
Portfolio Pulse from richadhand@benzinga.com
Stephens & Co. analyst Jacob Johnson reiterated an Overweight rating on Avid Bioservices (NASDAQ:CDMO) and maintained a $24 price target.
June 22, 2023 | 12:04 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Stephens & Co. analyst reaffirms Overweight rating on Avid Bioservices (NASDAQ:CDMO) and keeps $24 price target.
The reiteration of the Overweight rating and maintenance of the $24 price target by Stephens & Co. analyst Jacob Johnson indicates a positive outlook for Avid Bioservices. This news is likely to have a positive impact on the stock price in the short term as it shows confidence in the company's performance and potential growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100